• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Teladoc Health Inc.

    9/5/24 4:36:22 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care
    Get the next $TDOC alert in real time by email
    SC 13G 1 p24-2746sc13g.htm TELADOC HEALTH, INC.
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
    (Amendment No.  )*
     

    Teladoc Health, Inc.

    (Name of Issuer)
     

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)
     

    87918A105

    (CUSIP Number)
     

    September 4, 2024

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ¨ Rule 13d-1(b)
    ý Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 7 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    CUSIP No. 87918A10513GPage 2 of 7 Page

     

    1

    NAME OF REPORTING PERSON

     

    Point72 Asset Management, L.P.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) x

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.1%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

    CUSIP No. 87918A10513GPage 3 of 7 Page

     

     

    1

    NAME OF REPORTING PERSON

     

    Point72 Capital Advisors, Inc.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) x

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.1%

    12

    TYPE OF REPORTING PERSON

    CO

             

     

     

    CUSIP No. 87918A10513GPage 4 of 7 Page

     

     

    1

    NAME OF REPORTING PERSON

     

    Steven A. Cohen

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) x

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    8,754,723 (including 146,700 Shares issuable upon exercise of options)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.1%

    12

    TYPE OF REPORTING PERSON

    IN

             

     

     

    CUSIP No. 87918A10513GPage 5 of 7 Page

      

    Item 1(a). Name of Issuer.
      Teladoc Health, Inc. (the “Issuer”).

     

    Item 1(b). Address of Issuer's Principal Executive Offices.
      2 Manhattanville Road, Suite 203, Purchase, New York 10577.

     

    Item 2(a). Name of Person Filing.
      This statement is filed by: (i) Point72 Asset Management, L.P. (“Point72 Asset Management”) with respect to shares of common stock, par value $0.001 per share (“Shares”), of the Issuer held by (and underlying options held by) Point72 Associates, LLC, an investment fund it manages (“Point72 Associates”); (ii) Point72 Capital Advisors, Inc. (“Point72 Capital Advisors Inc.”) with respect to Shares held by (and underlying options held by) Point72 Associates; and (iii) Steven A. Cohen (“Mr. Cohen”) with respect to Shares beneficially owned by Point72 Asset Management and Point72 Capital Advisors Inc.
       
      Cubist Systematic Strategies, LLC, an advisor under common control with Point72 Asset Management, acts as a sub-advisor with respect to a portion of the Shares reported herein.
       
      Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

     

    Item 2(b). Address of Principal Business Office.
      The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.

     

    Item 2(c). Place of Organization.
      Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation.  Mr. Cohen is a United States citizen.

     

    Item 2(d). Title of Class of Securities.
      Common Stock, par value $0.001 per share.

     

    Item 2(e). CUSIP Number.
      87918A105

     

    Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a:
      Not applicable.

     

    CUSIP No. 87918A10513GPage 6 of 7 Page

     

    Item 4. Ownership.
      The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person.  Such information is as of the close of business on September 4, 2024.
       
      Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own directly no Shares. Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by Point72 Associates. Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management.  Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc.   The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Shares reported herein.

     

    Item 5. Ownership of Five Percent or Less of a Class.
      If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
      Point72 Associates has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the outstanding Shares.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
      Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.
      Not applicable.

     

    Item 9. Notice of Dissolution of Group.
      Not applicable.

     

    Item 10. Certification.
      By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    CUSIP No. 87918A10513GPage 7 of 7 Page

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date: September 5, 2024  
      POINT72 ASSET MANAGEMENT, L.P.
       
      By: /s/ Jason M. Colombo
      Name:  Jason M. Colombo
      Title:    Authorized Person
       
       
      POINT72 CAPITAL ADVISORS, INC.
       
      By: /s/ Jason M. Colombo
      Name:  Jason M. Colombo
      Title:    Authorized Person
       
       
      STEVEN A. COHEN
       
      By: /s/ Jason M. Colombo
      Name:  Jason M. Colombo
      Title:    Authorized Person

     

     

     

     

    Get the next $TDOC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TDOC

    DatePrice TargetRatingAnalyst
    11/15/2024$14.00Buy
    Goldman
    9/17/2024$8.00 → $10.00Hold
    Jefferies
    2/29/2024$22.00Overweight
    Cantor Fitzgerald
    2/26/2024$17.00Market Perform
    Leerink Partners
    1/17/2024$33.00 → $22.00Buy → Neutral
    DA Davidson
    1/3/2024$26.00Overweight
    Barclays
    4/12/2023$25.00Equal-Weight
    Stephens
    2/23/2023$34.00Market Perform → Outperform
    SVB Securities
    More analyst ratings

    $TDOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mckinley Thomas bought $30,756 worth of shares (4,000 units at $7.69), increasing direct ownership by 11% to 39,077 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      9/13/24 5:14:02 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Director Smith Mark Douglas bought $28,312 worth of shares (4,000 units at $7.08), increasing direct ownership by 92% to 8,355 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      8/19/24 4:10:41 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Director Mckinley Thomas bought $81,746 worth of shares (11,000 units at $7.43), increasing direct ownership by 46% to 35,077 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      8/8/24 5:49:44 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care

    $TDOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Teladoc Health Inc.

      SC 13G - Teladoc Health, Inc. (0001477449) (Subject)

      9/5/24 4:36:22 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Teladoc Health Inc.

      SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

      7/8/24 4:32:41 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Teladoc Health Inc. (Amendment)

      SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

      2/13/24 5:16:08 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care

    $TDOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Goldman initiated coverage on Teladoc with a new price target

      Goldman initiated coverage of Teladoc with a rating of Buy and set a new price target of $14.00

      11/15/24 8:22:14 AM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Jefferies reiterated coverage on Teladoc with a new price target

      Jefferies reiterated coverage of Teladoc with a rating of Hold and set a new price target of $10.00 from $8.00 previously

      9/17/24 8:21:59 AM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Cantor Fitzgerald initiated coverage on Teladoc with a new price target

      Cantor Fitzgerald initiated coverage of Teladoc with a rating of Overweight and set a new price target of $22.00

      2/29/24 7:33:55 AM ET
      $TDOC
      Medical/Nursing Services
      Health Care

    $TDOC
    Financials

    Live finance-specific insights

    See more

    $TDOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $TDOC
    SEC Filings

    See more
    • Teladoc Health Reports First Quarter 2025 Results

      PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 ("First Quarter 2024"). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill impairment charge of $59.1 million, or $0.34 per share, which occurred after the issuance of the previously provided outlook and was not included First Qu

      4/30/25 4:05:56 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits

      PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired UpLift, an innovative and tech-enabled provider of virtual mental health therapy, psychiatry and medication management services.    The acquisition supports the company's strategy to further enhance its leadership position in virtual mental health, including the ability for consumers served by its BetterHelp segment to access benefits coverage for mental health services. UpLift serves the health plan market and has arrangements covering over 100 million lives, a network of over 1,500 mental health professionals, important capabilities and a talent

      4/30/25 4:01:27 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Teladoc Health to Announce First Quarter 2025 Financial Results

      PURCHASE, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 309585. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=81196. A live audio webcast will also be available online at h

      4/16/25 6:00:23 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • CHIEF FINANCIAL OFFICER Murthy Mala converted options into 12,652 shares and sold $51,012 worth of shares (7,494 units at $6.81), increasing direct ownership by 4% to 121,467 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      4/8/25 4:23:48 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • CHIEF FINANCIAL OFFICER Murthy Mala converted options into 36,933 shares and sold $173,416 worth of shares (20,586 units at $8.42), increasing direct ownership by 16% to 116,309 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      3/21/25 4:20:30 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • CHIEF LEGAL OFFICER, SECRETARY Vandervoort Adam C converted options into 21,400 shares and sold $92,757 worth of shares (11,011 units at $8.42), increasing direct ownership by 19% to 64,308 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      3/21/25 4:20:16 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by Teladoc Health Inc.

      DEFA14A - Teladoc Health, Inc. (0001477449) (Filer)

      5/5/25 4:05:23 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Teladoc Health Inc.

      10-Q - Teladoc Health, Inc. (0001477449) (Filer)

      5/1/25 4:29:22 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Teladoc Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Teladoc Health, Inc. (0001477449) (Filer)

      4/30/25 4:05:52 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care

    $TDOC
    Leadership Updates

    Live Leadership Updates

    See more
    • Teladoc Health Board of Directors Announces Leadership Transition

      Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic's permanent successor. Ms. Murthy is a seasoned industry leader who has served as the Company's Chief Financial Officer since 2019, and she will continue serving in this role during this transition period. The Board has ret

      4/5/24 6:30:18 AM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

      PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

      9/20/23 8:05:00 AM ET
      $SGRY
      $TDOC
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • Gabriela Perez Joins Big Health as Chief Commercial Officer

      After spending two decades successfully scaling multiple healthcare technology companies, Perez joins Big Health to accelerate the commercial coverage and reimbursement for digital therapeutics Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced the appointment of Gabriela Perez as Chief Commercial Officer. In her new role, Perez will oversee Big Health's global commercial growth and strategy, including sales, client management, strategic partnerships, and new markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220203005297/en/Big Health Chief Commercial Office

      2/3/22 8:00:00 AM ET
      $LH
      $TDOC
      Medical Specialities
      Health Care
      Medical/Nursing Services

    $TDOC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare

      USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 6, 2025 /PRNewswire/ -- Healthcare is quickly evolving into a digital-first operation, where top executives in the sector are doubling down on artificial intelligence, automation and analytics to reduce costs and improve billing accuracy. This is according to results of a survey from Everest Group (and supported by Omega Healthcare), which showed 85% of senior healthcare executives believe AI will improve efficiencies over the next five years. Now that multitasking AI Agents are being referred to as hospitals' newest "employees", AI-powered electronic noses are detecting scents for health and enviro

      5/6/25 9:45:00 AM ET
      $AMZN
      $CLOV
      $TDOC
      Catalog/Specialty Distribution
      Consumer Discretionary
      Medical Specialities
      Health Care
    • Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

      PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees. Effective April 30, 2025, in connection with the acquisition of Uplift Health Technologies, Inc., four employees of Uplift Health were granted awards of restricted stock units covering an aggregate of 215,028 shares of Teladoc Health's common stock, par value $0.001 per share ("Common Stock"). The restricted stock units vest, based on continued service to Teladoc Health, over two or three years. Also, effective May 1, 2025, in connection with commencing employment, an additional new non-executive empl

      5/2/25 9:30:32 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Teladoc Health Reports First Quarter 2025 Results

      PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 ("First Quarter 2024"). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill impairment charge of $59.1 million, or $0.34 per share, which occurred after the issuance of the previously provided outlook and was not included First Qu

      4/30/25 4:05:56 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care